Clinical Trial Update: Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLC

View source ↗

Summary

This clinical trial update reports on the planned evaluation of SHR-A1811 for effectiveness and safety in Chinese patients with HER2-altered non-small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Nanjing Tianyinshan Hospital | Conditions: NSCLC | Status: NOT_YET_RECRUITING